- Report
- August 2024
- 175 Pages
Global
From €4753EUR$5,000USD£3,993GBP
- Report
- October 2024
- 250 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- September 2024
- 150 Pages
Global
From €4611EUR$4,850USD£3,873GBP
- Report
- January 2025
- 180 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2025
- 250 Pages
Global
From €4752EUR$4,999USD£3,992GBP
- Report
- October 2024
- 200 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- August 2024
- 200 Pages
Global
From €4705EUR$4,949USD£3,952GBP
- Report
- May 2024
- 160 Pages
Global
From €4724EUR$4,969USD£3,968GBP
- Report
- June 2024
- 270 Pages
Global
From €4749EUR$4,995USD£3,989GBP
- Report
- July 2024
- 158 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- July 2024
- 156 Pages
Global
From €4040EUR$4,250USD£3,394GBP
- Report
- May 2024
- 75 Pages
Global
From €9502EUR$9,995USD£7,982GBP
- Report
- January 2025
- 256 Pages
Global
From €4278EUR$4,500USD£3,594GBP
- Report
- January 2023
- 248 Pages
Global
From €4866EUR$5,298USD£3,950GBP
- Report
- October 2023
- 159 Pages
Global
From €2139EUR$2,250USD£1,797GBP
€4278EUR$4,500USD£3,594GBP
- Report
- September 2023
- 449 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- April 2023
- 286 Pages
Global
From €4706EUR$4,950USD£3,953GBP
- Report
- April 2023
- 145 Pages
Global
From €2377EUR$2,500USD£1,997GBP
- Report
- January 2022
- 79 Pages
Global
From €808EUR$850USD£679GBP
- Report
- July 2022
- 159 Pages
Global
From €2234EUR$2,350USD£1,877GBP

The Respiratory Disease market within the context of Pulmonary Medicine is a broad field of study that focuses on the diagnosis, treatment, and prevention of diseases that affect the lungs and airways. This includes conditions such as asthma, chronic obstructive pulmonary disease (COPD), interstitial lung disease, and pulmonary hypertension. Treatment options for these conditions range from lifestyle modifications to medications, and in some cases, surgery. Research in this field is ongoing, with the aim of improving the quality of life for those affected by respiratory diseases.
Companies in the Respiratory Disease market include AstraZeneca, Boehringer Ingelheim, GlaxoSmithKline, Merck, Novartis, and Pfizer. These companies are involved in the development of new treatments and therapies for respiratory diseases, as well as the manufacture and distribution of existing treatments. Show Less Read more